☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
neurodegenerative disease
Teva Signs an Exclusive WW License Agreement with Modag to Develop Anle138b and Sery433 for Neurodegenerative Disease
October 27, 2021
BMS Exercised Its Option to License Evotec's EVT8683 for the Treatment of Neurodegenerative Disease
September 2, 2021
Load more...
Back to Home
Modal title
×
Modal body text goes here.